On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Cardiac clearance” can reveal heart issues, reduce surgical risk and even save a life. The evaluation helps ensure your body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback